Lyell Immunopharma Inc
Biotechnology
Healthcare
LYEL
295 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
13.04
52 week high
31.20
high
13.48
52 week low
0.00
low
13.04
growth
-56.36 %
previous Close
13.17
P/E ratio
-5
market cap
203 M
div yield
0
net profit margin
0.00 %
745642.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top